151 related articles for article (PubMed ID: 8993241)
21. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.
Boldt J; Knothe C; Zickmann B; Wege N; Dapper F; Hempelmann G
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):705-11. PubMed ID: 7682266
[TBL] [Abstract][Full Text] [Related]
22. Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting.
Poston RS; White C; Gu J; Brown J; Gammie J; Pierson RN; Lee A; Connerney I; Avari T; Christenson R; Tandry U; Griffith BP
Ann Thorac Surg; 2006 Jan; 81(1):104-10; discussion 110-1. PubMed ID: 16368345
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin reduces intraoperative and postoperative blood loss in membrane oxygenator cardiopulmonary bypass.
Harder MP; Eijsman L; Roozendaal KJ; van Oeveren W; Wildevuur CR
Ann Thorac Surg; 1991 Jun; 51(6):936-41. PubMed ID: 1710098
[TBL] [Abstract][Full Text] [Related]
24. Leukocyte integrin expression in patients undergoing cardiopulmonary bypass.
Asimakopoulos G; Kohn A; Stefanou DC; Haskard DO; Landis RC; Taylor KM
Ann Thorac Surg; 2000 Apr; 69(4):1192-7. PubMed ID: 10800818
[TBL] [Abstract][Full Text] [Related]
25. Effect of reduced aprotinin dosage on blood loss and use of blood products in patients undergoing cardiopulmonary bypass.
Liu B; Belboul A; Rådberg G; Tengborn L; Dernevik L; Roberts D; William-Olsson G
Scand J Thorac Cardiovasc Surg; 1993; 27(3-4):149-55. PubMed ID: 7515193
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery.
Huang H; Ding W; Su Z; Zhang W
J Thorac Cardiovasc Surg; 1993 Jul; 106(1):11-8. PubMed ID: 7686594
[TBL] [Abstract][Full Text] [Related]
27. Amelioration of the bleeding tendency of preoperative aspirin after aortocoronary bypass grafting.
Bidstrup BP; Hunt BJ; Sheikh S; Parratt RN; Bidstrup JM; Sapsford RN
Ann Thorac Surg; 2000 Feb; 69(2):541-7. PubMed ID: 10735695
[TBL] [Abstract][Full Text] [Related]
28. The impact of aprotinin on blood loss and blood transfusion in off-pump coronary artery bypass grafting.
Bittner HB; Lemke J; Lange M; Rastan A; Mohr FW
Ann Thorac Surg; 2008 May; 85(5):1662-8. PubMed ID: 18442562
[TBL] [Abstract][Full Text] [Related]
29. The effect of two different doses of aprotinin on hemostasis in cardiopulmonary bypass surgery: similar transfusion requirements and blood loss.
Santamaría A; Mateo J; Oliver A; Litvan H; Murillo J; Souto JC; Fontcuberta J
Haematologica; 2000 Dec; 85(12):1277-84. PubMed ID: 11114135
[TBL] [Abstract][Full Text] [Related]
30. Defining the role of aprotinin in heart transplantation.
Prendergast TW; Furukawa S; Beyer AJ; Eisen HJ; McClurken JB; Jeevanandam V
Ann Thorac Surg; 1996 Sep; 62(3):670-4. PubMed ID: 8783991
[TBL] [Abstract][Full Text] [Related]
31. Does aprotinin influence the inflammatory response to cardiopulmonary bypass in patients?
Schmartz D; Tabardel Y; Preiser JC; Barvais L; d'Hollander A; Duchateau J; Vincent JL
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):184-90. PubMed ID: 12539003
[TBL] [Abstract][Full Text] [Related]
32. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).
Bidstrup BP; Royston D; Sapsford RN; Taylor KM
J Thorac Cardiovasc Surg; 1989 Mar; 97(3):364-72. PubMed ID: 2465457
[TBL] [Abstract][Full Text] [Related]
33. Comparison of two doses of aprotinin in patients receiving aspirin before coronary bypass surgery.
Moran SV; Lema G; Medel J; Irarrazaval MJ; Zalaquett R; Garayar B; Flaskamp R
Perfusion; 2000 Mar; 15(2):105-10. PubMed ID: 10789564
[TBL] [Abstract][Full Text] [Related]
34. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
35. Blood conservation techniques and platelet function in cardiac surgery.
Boldt J; Zickmann B; Czeke A; Herold C; Dapper F; Hempelmann G
Anesthesiology; 1991 Sep; 75(3):426-32. PubMed ID: 1716079
[TBL] [Abstract][Full Text] [Related]
36. A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting.
Levy JH; Pifarre R; Schaff HV; Horrow JC; Albus R; Spiess B; Rosengart TK; Murray J; Clark RE; Smith P
Circulation; 1995 Oct; 92(8):2236-44. PubMed ID: 7554207
[TBL] [Abstract][Full Text] [Related]
37. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
[TBL] [Abstract][Full Text] [Related]
38. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost.
Ray MJ; O'Brien MF
Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462
[TBL] [Abstract][Full Text] [Related]
39. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin.
Speekenbrink RG; Bertina RM; España F; Wildevuur CR; Eijsman L
Ann Thorac Surg; 1998 Dec; 66(6):1998-2002. PubMed ID: 9930483
[TBL] [Abstract][Full Text] [Related]
40. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
